GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Estrella Immunopharma Inc (NAS:ESLA) » Definitions » Inventories, Raw Materials & Components

Estrella Immunopharma (Estrella Immunopharma) Inventories, Raw Materials & Components : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Estrella Immunopharma Inventories, Raw Materials & Components?

Estrella Immunopharma's inventories, raw materials & components for the quarter that ended in Dec. 2023 was $0.00 Mil.


Estrella Immunopharma Inventories, Raw Materials & Components Historical Data

The historical data trend for Estrella Immunopharma's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Estrella Immunopharma Inventories, Raw Materials & Components Chart

Estrella Immunopharma Annual Data
Trend Jun21
Inventories, Raw Materials & Components
-

Estrella Immunopharma Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Sep23 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial - - - - -

Estrella Immunopharma Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Estrella Immunopharma (Estrella Immunopharma) Business Description

Industry
Traded in Other Exchanges
N/A
Address
5858 Horton Street, Suite 170, Emeryville, CA, USA, 94608
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Estrella Immunopharma (Estrella Immunopharma) Headlines

No Headlines